Develops and commercializes diagnostic radiopharmaceuticals and contrast agents used in medical imaging, particularly for oncology and cardiology. Its flagship product, Pylarify, is a PSMA-targeted PET imaging agent widely used in detecting and staging prostate cancer, driving a significant share of...
This page tracks all publicly disclosed congressional trades in Lantheus Holdings, Inc. (LNTH), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 4 purchases and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-01-28 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-13 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-08 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-07 | Gilbert Cisneros | buy | $1K – $15K |